Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott's Humira Approved For Psoriatic Arthritis, First-Line Rheumatoid Arthritis

This article was originally published in The Pink Sheet Daily

Executive Summary

Abbott will support dedicated sales representatives to detail Humira to dermatologists following psoriatic arthritis approval.
Advertisement

Related Content

Humira Cleared For Additional Psoriatic Arthritis Indication
Humira Cleared For Additional Psoriatic Arthritis Indication
J&J/Centocor Seek To Expand Remicade Psoriatic Arthritis Indication
J&J/Centocor Seek To Expand Remicade Psoriatic Arthritis Indication
Enbrel Growth Plans Include Copay Assistance, DTC
Humira Sales Will Get Modest Bump From Medicare Part D, Abbott Says
Humira sBLA Submitted For Ankylosing Spondylitis
Humira sBLA Submitted For Ankylosing Spondylitis
J&J's Remicade Adds Psoriatic Arthritis Indication
J&J's Remicade Adds Psoriatic Arthritis Indication

Topics

Advertisement
UsernamePublicRestriction

Register

PS061203

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel